NM_001290223.2:c.3224+255C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001290223.2(DOCK1):c.3224+255C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 151,996 control chromosomes in the GnomAD database, including 20,783 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 20783 hom., cov: 32)
Consequence
DOCK1
NM_001290223.2 intron
NM_001290223.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.495
Publications
2 publications found
Genes affected
DOCK1 (HGNC:2987): (dedicator of cytokinesis 1) This gene encodes a member of the dedicator of cytokinesis protein family. Dedicator of cytokinesis proteins act as guanine nucleotide exchange factors for small Rho family G proteins. The encoded protein regulates the small GTPase Rac, thereby influencing several biological processes, including phagocytosis and cell migration. Overexpression of this gene has also been associated with certain cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.59 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DOCK1 | ENST00000623213.2 | c.3224+255C>T | intron_variant | Intron 31 of 51 | 1 | NM_001290223.2 | ENSP00000485033.1 | |||
| DOCK1 | ENST00000280333.9 | c.3161+255C>T | intron_variant | Intron 31 of 51 | 1 | ENSP00000280333.6 | ||||
| DOCK1 | ENST00000484400.5 | n.378-198C>T | intron_variant | Intron 4 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.511 AC: 77676AN: 151874Hom.: 20779 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
77676
AN:
151874
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.511 AC: 77709AN: 151996Hom.: 20783 Cov.: 32 AF XY: 0.505 AC XY: 37495AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
77709
AN:
151996
Hom.:
Cov.:
32
AF XY:
AC XY:
37495
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
16180
AN:
41444
American (AMR)
AF:
AC:
7275
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2430
AN:
3464
East Asian (EAS)
AF:
AC:
1637
AN:
5158
South Asian (SAS)
AF:
AC:
2782
AN:
4830
European-Finnish (FIN)
AF:
AC:
5100
AN:
10544
Middle Eastern (MID)
AF:
AC:
198
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40439
AN:
67952
Other (OTH)
AF:
AC:
1161
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1880
3759
5639
7518
9398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1667
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.